Your browser doesn't support javascript.
loading
The use of digital tools in rare neurological diseases towards a new care model: a narrative review.
Torri, Francesca; Vadi, Gabriele; Meli, Adriana; Loprieno, Sara; Schirinzi, Erika; Lopriore, Piervito; Ricci, Giulia; Siciliano, Gabriele; Mancuso, Michelangelo.
Afiliación
  • Torri F; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Vadi G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Meli A; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Loprieno S; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Schirinzi E; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Lopriore P; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Ricci G; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Siciliano G; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
  • Mancuso M; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.
Neurol Sci ; 45(10): 4657-4668, 2024 Oct.
Article en En | MEDLINE | ID: mdl-38856822
ABSTRACT
Rare neurological diseases as a whole share peculiar features as motor and/or cognitive impairment, an elevated disability burden, a frequently chronic course and, in present times, scarcity of therapeutic options. The rarity of those conditions hampers both the identification of significant prognostic outcome measures, and the development of novel therapeutic approaches and clinical trials. Collection of objective clinical data through digital devices can support diagnosis, care, and therapeutic research. We provide an overview on recent developments in the field of digital tools applied to rare neurological diseases, both in the care setting and as providers of outcome measures in clinical trials in a representative subgroup of conditions, including ataxias, hereditary spastic paraplegias, motoneuron diseases and myopathies.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Raras / Enfermedades del Sistema Nervioso Límite: Humans Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Raras / Enfermedades del Sistema Nervioso Límite: Humans Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Italia